About the Center for Pharmaceutical Policy and Prescribing

The Center for Pharmaceutical Policy and Prescribing (CP3) was established in October 2013 and celebrated its launch with an inaugural lecture by Dr. William Shrank, of Harvard Medical School, entitled "How Health Reform Paves the Way for Improving Medication Use". The mission of CP3 is to foster multidisciplinary collaboration to improve the quality, safety, and efficiency of medication use.  The Center’s focus is on informing the regulation and coverage of pharmaceuticals and improving patient and prescriber decision-making on prescription drugs. Prescription drugs are used by 80% of Americans and are essential in the treatment and prevention of acute and chronic conditions.  The improper, unsafe, and inefficient use of medications leads to billions of dollars of avoidable healthcare costs. 

Center faculty conduct research in the following areas:  

Quality and value of prescribing

  • Provider practice variation
  • Optimizing use of generic drugs
  • Understanding prescribing in an era of personalized medicine
  • Pharmaceutical pricing

Insurance and benefit design

  • Pharmaceutical benefit design and cost-sharing
  • Impact of formulary and utilization management tools
  • Medicare and Medicaid drug coverage

Diffusion of new drugs

  • Provider adoption of new drugs
  • Regional variation in use of high cost drugs, including biologics
  • Pharmaceutical promotion and prescriber conflicts of interest

Drug Safety

  • Detecting and preventing adverse drug events using novel technology
  • Pharmacovigilance and pharmacoepidemiology studies
  • Quality and safety of medication use in older adults in nursing homes

Medication adherence

  • Novel techniques for measuring adherence
  • Applying new technology to improve adherence